Apr. 2026
日本臨床免疫学会, JSCI-FOCIS Emerging Investigator Recognition Award 2026

Apr. 2026
日本リウマチ学会, ICW Excellent Abstract Award

Aug. 2024
日本脊椎関節炎学会, 2024 JSAS dragon award

Apr. 2024
日本リウマチ学会, ICW Excellent Abstract Award

Dec. 2022
日本免疫学会, Best Poster Award

Apr. 2022
日本リウマチ学会, ICW Excellent Abstract Award

Short-chain fatty acid deficiency drives aberrant B cell differentiation in systemic lupus erythematosus.
Ryuichiro Kanda; Satoshi Kubo; Kaoru Yamagata; Shigeru Iwata; Yasuyuki Todoroki; Masanobu Ueno; Atsushi Nagayasu; Yurie Satoh-Kanda; Ippei Miyagawa; Koshiro Sonomoto; Yoshiya Tanaka; Shingo Nakayamada
Clinical immunology (Orlando, Fla.), Apr. 2026

Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST Registry.
Naoaki Ohkubo; Yusuke Miyazaki; Satoshi Kubo; Ippei Miyagawa; Koshiro Sonomoto; Yoshino Inoue; Yurie Satoh-Kanda; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Kiyotake Yoshioka; Mayu Nishimoto; Kazuki Takahashi; Shingo Nakayamada; Yoshiya Tanaka
Modern rheumatology, Mar. 2026

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.
Takafumi Aritomi; Koshiro Sonomoto; Shingo Nakayamada; Hiroaki Tanaka; Atsushi Nagayasu; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Naoaki Ohkubo; Yasuyuki Todoroki; Yurie Satoh-Kanda; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Masashi Funada; Hidenori Sakai; Satsuki Matsunaga; Hiroaki Tanaka; Masayuki Shinojima; Hiroki Kawamura; Kazuki Takahashi; Miyabi Ando; Kazuki Haru; Yusuke Miyazaki; Kentaro Hanami; Masao Nawata; Shunsuke Fukuyo; Keisuke Nakatsuka; Mikiko Tokunaga; Kazuyoshi Saito; Yoshiya Tanaka
Arthritis & rheumatology (Hoboken, N.J.), Mar. 2026

Real-world effectiveness of b/tsDMARD switching in low-inflammatory difficult-to-treat rheumatoid arthritis: insights from the FIRST registry.
Hidenori Sakai; Koshiro Sonomoto; Shingo Nakayamada; Masanobu Ueno; Atsushi Nagayasu; Takafumi Aritomi; Hiroaki Tanaka; Satoshi Kubo; Ippei Miyagawa; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Ryuichiro Kanda; Yoshiya Tanaka
RMD open, Feb. 2026

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry.
Koshiro Sonomoto; Shingo Nakayamada; Hidenori Sakai; Masanobu Ueno; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Makoto Okawara; Akinori Nakata; Yoshiya Tanaka
RMD open, Jan. 2026

Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry.
Masanobu Ueno; Koshiro Sonomoto; Hiroaki Tanaka; Atsushi Nagayasu; Takafumi Aritomi; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Yurie Satoh-Kanda; Yuya Fujita; Hidenori Sakai; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Jan. 2026

Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene.
Kyuto Sonehara; Rei Watanabe; Yutaka Matsumura; Yuichi Mitsui; Yosuke Ogawa; Kaori Odomari; Saori Sakaue; Shinichi Namba; Mariko Komuro; Mio Edamoto; Junya Watanabe; Tomomitsu Hirota; Noriko Arase; Yuumi Nakamura; Kimiko Nakajima; Takashi Okamoto; Rika Nishikawa; Kenichi Yamamoto; Ken Suzuki; Toshihiro Kishikawa; Ryuya Edahiro; Yuya Shirai; Tatsuhiko Naito; Noah Sasa; Yosuke Ishitsuka; Junichi Furuta; Kayo Kunimoto; Ikko Kajihara; Satoshi Fukushima; Hideaki Miyachi; Hiroyuki Matsue; Masahiro Kamata; Mami Momose; Ippei Miyagawa; Hiroaki Tanaka; Masanobu Ueno; Toshinori Bito; Hiroshi Nagai; Tetsuya Ikeda; Tatsuya Horikawa; Atsuko Adachi; Tsukasa Matsubara; Emi Nishida; Koichi Matsuda; Nobuhiro Shojima; Ikuma Nakagawa; Yoshihide Asano; Shinichi Sato; Shinichi Imafuku; Yayoi Tada; Chikako Nishigori; Masatoshi Jinnin; Hironobu Ihn; Akihiko Asahina; Hidehisa Saeki; Toshimasa Yamauchi; Takashi Kadowaki; Tatsuyoshi Kawamura; Shinji Shimada; Ichiro Katayama; Koichiro Higasa; Emiko Noguchi; Shigetoshi Sano; Yoshiya Tanaka; Fumihiko Matsuda; Atsushi Kumanogoh; Mayumi Tamari; Takashi Satoh; Manabu Fujimoto; Akimichi Morita; Yukinori Okada
Cell genomics, Oct. 2025

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from the FIRST registry.
Satoshi Kubo; Yusuke Miyazaki; Hiroaki Tanaka; Yuya Fujita; Hidenori Sakai; Masanobu Ueno; Yasuyuki Todoroki; Yurie Satoh-Kanda; Ippei Miyagawa; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology (Oxford, England), Sep. 2025

Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study.
Katsuhide Kusaka; Satoshi Kubo; Shingo Nakayamada; Ippei Miyagawa; Yusuke Miyazaki; Yurie Kanda; Yasuyuki Todoroki; Masanobu Ueno; Ryuichiro Kanda; Koshi Setoyama; Masaharu Kataoka; Yoshiya Tanaka
Arthritis research & therapy, Aug. 2025

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Atsushi Nagayasu; Yusuke Miyazaki; Koshiro Sonomoto; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Hiroaki Tanaka; Yasuyuki Todoroki; Masanobu Ueno; Takafumi Aritomi; Yuya Fujita; Hidenori Sakai; Katsunori Suzuki; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Aug. 2025

An autopsy of a patient with polyarteritis nodosa who developed fatal intestinal perforation accompanied by systemic multiple aneurysms and arterial thrombosis.
Nao Tsugita; Ippei Miyagawa; Masanobu Ueno; Miyabi Takahashi; Shumpei Kosaka; Shingo Nakayamada; Yoshiya Tanaka
Modern rheumatology case reports, Jul. 2025

A case of Erdheim-Chester disease-a mimicker of IgG4-related disease and large vessel vasculitis.
Ippei Miyagawa; Shingo Nakayamada; Hirotsugu Nohara; Shumpei Kosaka; Masanobu Ueno; Yoshiya Tanaka
Modern rheumatology case reports, Jul. 2025

A case of newly onset rheumatoid arthritis successfully treated with methotrexate under the antiretrovirus therapy against HIV infection.
Ippei Miyagawa; Shingo Nakayamada; Kazuyoshi Saito; Shoichi Shimizu; Kentaro Hanami; Masanobu Ueno; Yoshiya Tanaka
Modern rheumatology case reports, Jul. 2025

The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis.
Katsuhide Kusaka; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Ippei Miyagawa; Yurie Satoh-Kanda; Yasuyuki Todoroki; Masanobu Ueno; Yoshiya Tanaka
Modern rheumatology, Apr. 2025

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST registry.
Yusuke Miyazaki; Shingo Nakayamada; Hiroaki Tanaka; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yasuyuki Todoroki; Yoshino Inoue; Masanobu Ueno; Yoshiya Tanaka
Rheumatology (Oxford, England), Apr. 2025

Efficacy, safety and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Hidenori Sakai; Yusuke Miyazaki; Shingo Nakayamada; Satoshi Kubo; Kentaro Hanami; Shunsuke Fukuyo; Ayako Yamaguchi; Ippei Miyagawa; Masanobu Ueno; Hiroaki Tanaka; Yasuyuki Todoroki; Naoaki Ohkubo; Masashi Funada; Satsuki Matsunaga; Yoshiya Tanaka
Rheumatology (Oxford, England), Apr. 2025

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Ryuichiro Kanda; Yusuke Miyazaki; Shingo Nakayamada; Shunsuke Fukuyo; Satoshi Kubo; Ippei Miyagawa; Ayako Yamaguchi; Yurie Satoh-Kanda; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroaki Tanaka; Masanobu Ueno; Atsushi Nagayasu; Yuya Fujita; Takafumi Aritomi; Katsuhide Kusaka; Hidenori Sakai; Satsuki Matsunaga; Hirotsugu Nohara; Yoshiya Tanaka
Rheumatology and therapy, Apr. 2025

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Satoshi Kubo; Yusuke Miyazaki; Takahiro Nishino; Yuya Fujita; Michihiro Kono; Tsugumi Kawashima; Kazuyoshi Ishigaki; Katsuhide Kusaka; Hiroaki Tanaka; Masanobu Ueno; Yurie Satoh-Kanda; Yoshino Inoue; Yasuyuki Todoroki; Ippei Miyagawa; Kentaro Hanami; Shingo Nakayamada; Yoshiya Tanaka
Annals of the rheumatic diseases, Feb. 2025

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Yusuke Miyazaki; Shingo Nakayamada; Hiroaki Tanaka; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ayako Yamaguchi; Ippei Miyagawa; Yurie Satoh-Kanda; Yasuyuki Todoroki; Yoshino Inoue; Masanobu Ueno; Yoshiya Tanaka
RMD open, Jan. 2025

Epstein-Barr virus-encoded RNA-positive lymphocytes in bone marrow and lymph nodes in an autopsy case of TAFRO syndrome.
Nao Tsugita; Ippei Miyagawa; Shingo Nakayamada; Aya Nawata; Shumpei Kosaka; Masanobu Ueno; Yoshiya Tanaka
Modern rheumatology case reports, Jan. 2025

Blood DNA virome associates with autoimmune diseases and COVID-19.
Noah Sasa; Shohei Kojima; Rie Koide; Takanori Hasegawa; Ho Namkoong; Tomomitsu Hirota; Rei Watanabe; Yuumi Nakamura; Eri Oguro-Igashira; Kotaro Ogawa; Tomohiro Yata; Kyuto Sonehara; Kenichi Yamamoto; Toshihiro Kishikawa; Saori Sakaue; Ryuya Edahiro; Yuya Shirai; Yuichi Maeda; Takuro Nii; Shotaro Chubachi; Hiromu Tanaka; Haruka Yabukami; Akari Suzuki; Kimiko Nakajima; Noriko Arase; Takashi Okamoto; Rika Nishikawa; Shinichi Namba; Tatsuhiko Naito; Ippei Miyagawa; Hiroaki Tanaka; Masanobu Ueno; Yosuke Ishitsuka; Junichi Furuta; Kayo Kunimoto; Ikko Kajihara; Satoshi Fukushima; Hideaki Miyachi; Hiroyuki Matsue; Masahiro Kamata; Mami Momose; Toshinori Bito; Hiroshi Nagai; Tetsuya Ikeda; Tatsuya Horikawa; Atsuko Adachi; Tsukasa Matsubara; Kyoko Ikumi; Emi Nishida; Ikuma Nakagawa; Mayu Yagita-Sakamaki; Maiko Yoshimura; Shiro Ohshima; Makoto Kinoshita; Satoru Ito; Toru Arai; Masaki Hirose; Yoshinori Tanino; Takefumi Nikaido; Toshio Ichiwata; Shinya Ohkouchi; Taizou Hirano; Toshinori Takada; Ryushi Tazawa; Konosuke Morimoto; Masahiro Takaki; Satoshi Konno; Masaru Suzuki; Keisuke Tomii; Atsushi Nakagawa; Tomohiro Handa; Kiminobu Tanizawa; Haruyuki Ishii; Manabu Ishida; Toshiyuki Kato; Naoya Takeda; Koshi Yokomura; Takashi Matsui; Akifumi Uchida; Hiromasa Inoue; Kazuyoshi Imaizumi; Yasuhiro Goto; Hiroshi Kida; Tomoyuki Fujisawa; Takafumi Suda; Takashi Yamada; Yasuomi Satake; Hidenori Ibata; Mika Saigusa; Toshihiro Shirai; Nobuyuki Hizawa; Koh Nakata; Shinichi Imafuku; Yayoi Tada; Yoshihide Asano; Shinichi Sato; Chikako Nishigori; Masatoshi Jinnin; Hironobu Ihn; Akihiko Asahina; Hidehisa Saeki; Tatsuyoshi Kawamura; Shinji Shimada; Ichiro Katayama; Hannah M Poisner; Taralynn M Mack; Alexander G Bick; Koichiro Higasa; Tatsusada Okuno; Hideki Mochizuki; Makoto Ishii; Ryuji Koike; Akinori Kimura; Emiko Noguchi; Shigetoshi Sano; Hidenori Inohara; Manabu Fujimoto; Yoshikazu Inoue; Etsuro Yamaguchi; Seishi Ogawa; Takanori Kanai; Akimichi Morita; Fumihiko Matsuda; Mayumi Tamari; Atsushi Kumanogoh; Yoshiya Tanaka; Koichiro Ohmura; Koichi Fukunaga; Seiya Imoto; Satoru Miyano; Nicholas F Parrish; Yukinori Okada
Nature genetics, Jan. 2025

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Masanobu Ueno; Shigeru Iwata; Kaoru Yamagata; Yasuyuki Todoroki; Koshiro Sonomoto; Atsushi Nagayasu; Ippei Miyagawa; Satoshi Kubo; Yusuke Miyazaki; Hiroko Miyata; Ryuichiro Kanda; Takafumi Aritomi; Shingo Nakayamada; Yoshiya Tanaka
RMD open, Dec. 2024

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Yoichi Nakayama; Wataru Nagata; Yoichi Takeuchi; Sho Fukui; Yuya Fujita; Yohei Hosokawa; Masanobu Ueno; Kumiko Ono; Shuji Sumitomo; Yuya Tabuchi; Yuichiro Nakanishi; Shuntaro Saito; Hiroko Ikeuchi; Kazutaka Kawamori; Hideaki Sofue; Goro Doi; Runa Minami; Tomoya Hirota; Kaoru Minegishi; Keisuke Maeshima; Ryo Motoyama; Shohei Nakamura; Shotaro Suzuki; Norihiro Nishioka; Takuma Tsuzuki Wada; Akira Onishi; Kenichi Nishimura; Ryu Watanabe; Ryo Yanai; Takashi Kida; Hiroki Nishiwaki; Nobuyuki Yajima; Yuko Kaneko; Eiichi Tanaka; Yutaka Kawahito; Masayoshi Harigai
Modern rheumatology, Oct. 2024

Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
Yusuke Miyazaki; Masashi Funada; Shingo Nakayamada; Koshiro Sonomoto; Hiroaki Tanaka; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Ayako Yamaguchi; Ippei Miyagawa; Yasuyuki Todoroki; Masanobu Ueno; Yoshiya Tanaka
Rheumatology (Oxford, England), Sep. 2024

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Koshiro Sonomoto; Shingo Nakayamada; Yoshihisa Fujino; Hiroko Miyata; Satoshi Kubo; Yuya Fujita; Yoshino Inoue; Satsuki Matsunaga; Shigeru Iwata; Kentaro Hanami; Yasuyuki Todoroki; Hiroko Yoshinari-Korekoda; Akio Kawabe; Ayako Yamaguchi; Masanobu Ueno; Yurie Satoh-Kanda; Ryuichiro Kanda; Masashi Funada; Naoaki Ohkubo; Katsuhide Kusaka; Shumpei Kosaka; Atsushi Nagayasu; Shunsuke Fukuyo; Masao Nawata; Yusuke Miyazaki; Mikiko Tokunaga; Kenichi Tanaka; Yosuke Okada; Yoshiya Tanaka
Rheumatology (Oxford, England), Aug. 2024

The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.
Yoshiya Tanaka; Satoshi Soen; Shintaro Hirata; Yosuke Okada; Saeko Fujiwara; Ikuko Tanaka; Yuriko Kitajima; Takuo Kubota; Kosuke Ebina; Yuichi Takashi; Reiko Inoue; Mika Yamauchi; Naoaki Okubo; Masanobu Ueno; Yasuhisa Ohata; Nobuaki Ito; Keiichi Ozono; Hisanori Nakayama; Masakazu Terauchi; Sakae Tanaka; Seiji Fukumoto
Journal of bone and mineral metabolism, Mar. 2024

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Satoshi Kubo; Yusuke Miyazaki; Yasuyuki Todoroki; Atsushi Nagayasu; Ryuichiro Kanda; Takafumi Aritomi; Satsuki Matsunaga; Masanobu Ueno; Ippei Miyagawa; Koshiro Sonomoto; Kentaro Hanami; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology and therapy, Dec. 2023

TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus.
Yu Shan; Shingo Nakayamada; Aya Nawata; Kaoru Yamagata; Koshiro Sonomoto; Hiroaki Tanaka; Yurie Satoh-Kanda; Mai-Phuong Nguyen; Yasuyuki Todoroki; Atsushi Nagayasu; Masanobu Ueno; Ryuichiro Kanda; Yuya Fujita; Tong Zhang; He Hao; Jieqing Zhou; Xiaoxue Ma; Junpei Anan; Anh Phuong Nguyen; Yoshiya Tanaka
Rheumatology (Oxford, England), Jul. 2023

Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Masanobu Ueno; Ippei Miyagawa; Yusuke Miyazaki; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Shingo Nakayamada; Yoshiya Tanaka
Arthritis research & therapy, Feb. 2023

Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Yasuyuki Todoroki; Satoshi Kubo; Kazuhisa Nakano; Yusuke Miyazaki; Masanobu Ueno; Yurie Satoh-Kanda; Ryuichiro Kanda; Ippei Miyagawa; Kentaro Hanami; Keisuke Nakatsuka; Kazuyoshi Saito; Shingo Nakayamada; Yoshiya Tanaka
Rheumatology (Oxford, England), Nov. 2022

Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Masanobu Ueno; Ippei Miyagawa; Yusuke Miyazaki; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Shingo Nakayamada; Yoshiya Tanaka
Arthritis research & therapy, Oct. 2022

An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus.
Maiko Hajime Sumikawa; Shigeru Iwata; Mingzeng Zhang; Hiroko Miyata; Masanobu Ueno; Yasuyuki Todoroki; Atsushi Nagayasu; Ryuichiro Kanda; Koshiro Sonomoto; Keiichi Torimoto; Seunghyun Lee; Shingo Nakayamada; Kazuo Yamamoto; Yosuke Okada; Yoshiya Tanaka
Rheumatology (Oxford, England), Jul. 2022

mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors.
Mingzeng Zhang; Shigeru Iwata; Koshiro Sonomoto; Masanobu Ueno; Yuya Fujita; Junpei Anan; Yusuke Miyazaki; Naoaki Ohkubo; Maiko Hajime Sumikawa; Yasuyuki Todoroki; Hiroko Miyata; Atsushi Nagayasu; Ryuichiro Kanda; He Hao; Gulzhan Trimova; Seunghyun Lee; Shingo Nakayamada; Kei Sakata; Yoshiya Tanaka
Rheumatology (Oxford, England), Jul. 2022

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study.
Masanobu Ueno; Ippei Miyagawa; Takafumi Aritomi; Koichi Kimura; Shigeru Iwata; Kentaro Hanami; Syunsuke Fukuyo; Satoshi Kubo; Yusuke Miyazaki; Shingo Nakayamada; Yoshiya Tanaka
Arthritis research & therapy, Jun. 2022

A patient with eosinophilic granulomatosis with polyangiitis successfully weaned from corticosteroids through remission induction therapy with mepolizumab.
Masanobu Ueno; Ippei Miyagawa; Akio Kawabe; Katsuhide Kusaka; Shingo Nakayamada; Yoshiya Tanaka
Modern rheumatology case reports, Jun. 2022

Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth.
Mengyue Shen; Duo Wang; Yusuke Sennari; Zirui Zeng; Ryoko Baba; Hiroyuki Morimoto; Noriaki Kitamura; Tsukasa Nakanishi; Junichi Tsukada; Masanobu Ueno; Yasuyuki Todoroki; Shigeru Iwata; Tomo Yonezawa; Yoshiya Tanaka; Yoshio Osada; Yasuhiro Yoshida
Medical oncology (Northwood, London, England), Jun. 2022

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Ippei Miyagawa; Shingo Nakayamada; Masanobu Ueno; Yusuke Miyazaki; Shigeru Iwata; Satoshi Kubo; Koshiro Sonomoto; Junpei Anan; Naoaki Ohkubo; Yoshino Inoue; Yoshiya Tanaka
Arthritis research & therapy, Apr. 2022

Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Ippei Miyagawa; Shingo Nakayamada; Masanobu Ueno; Yusuke Miyazaki; Naoaki Ohkubo; Yoshino Inoue; Satoshi Kubo; Yoshiya Tanaka
Frontiers in medicine, 2022

Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis.
Shigeru Iwata; Mingzeng Zhang; Maiko Hajime; Naoaki Ohkubo; Koshiro Sonomoto; Keiichi Torimoto; Yukihiro Kitanaga; Gulzhan Trimova; Yasuyuki Todoroki; Hiroko Miyata; Masanobu Ueno; Atsushi Nagayasu; Ryuichiro Kanda; Kazuhisa Nakano; Shingo Nakayamada; Kei Sakata; Yoshiya Tanaka
Rheumatology (Oxford, England), Nov. 2021

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis.
Masanobu Ueno; Ippei Miyagawa; Kazuhisa Nakano; Shigeru Iwata; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Yusuke Miyazaki; Akio Kawabe; Hiroko Yoshinari; Shingo Nakayamada; Yoshiya Tanaka
Arthritis research & therapy, Mar. 2021

Five Cases of IgG4-related Disease with Nasal Mucosa and Sinus Involvement.
Masanobu Ueno; Kazuhisa Nakano; Ippei Miyagawa; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), Aug. 2020

Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2.
Mingzeng Zhang; Shigeru Iwata; Maiko Hajime; Naoaki Ohkubo; Yasuyuki Todoroki; Hiroko Miyata; Masanobu Ueno; He Hao; Tong Zhang; Jie Fan; Shingo Nakayamada; Kaoru Yamagata; Yoshiya Tanaka
Arthritis & rheumatology (Hoboken, N.J.), Jul. 2020

Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
Masashi Funada; Kazuhisa Nakano; Ippei Miyagawa; Masanobu Ueno; Yoshiya Tanaka
Modern rheumatology case reports, Jul. 2020

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Ippei Miyagawa; Kazuhisa Nakano; Shingo Nakayamada; Shigeru Iwata; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Akio Kawabe; Yusuke Miyazaki; Yoshino Inoue; Masanobu Ueno; Naoaki Ohkubo; Yuya Fujita; Yoshiya Tanaka
International journal of rheumatic diseases, Apr. 2020

Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
Shigeru Iwata; Mingzeng Zhang; He Hao; Gulzhan Trimova; Maiko Hajime; Yusuke Miyazaki; Naoaki Ohkubo; Yurie Satoh Kanda; Yasuyuki Todoroki; Hiroko Miyata; Masanobu Ueno; Atsushi Nagayasu; Shingo Nakayamada; Kei Sakata; Yoshiya Tanaka
Frontiers in immunology, 2020

An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis.
Masanobu Ueno; Kazuhisa Nakano; Hiroko Yoshinari; Shingo Nakayamada; Shigeru Iwata; Satoshi Kubo; Ippei Miyagawa; Yoshiya Tanaka
Internal medicine (Tokyo, Japan), Apr. 2019

Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
Ippei Miyagawa; Kazuhisa Nakano; Shingo Nakayamada; Shigeru Iwata; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Yoshino Inoue; Masanobu Ueno; Yoshiya Tanaka
International journal of rheumatic diseases, Mar. 2019

SLEにおけるリツキシマブ療法
上野 匡庸, 中山田 真吾, 田中 良哉
リウマチ科, Aug. 2024, Reviewed, No invitation
Lead

【SLE診療の進歩】SLEにおけるB細胞を標的とした治療の作用機序と有用性
上野 匡庸, 中山田 真吾, 田中 良哉
リウマチ科, Feb. 2023, Reviewed, No invitation
Lead

無症候性IgG4関連胆嚢炎を伴ったIgG4関連疾患の一例
日下 勝秀, 中野 和久, 吉成 紘子, 岩田 慈, 福與 俊介, 花見 健太郎, 久保 智史, 宮川 一平, 河邊 明男, 宮崎 佑介, 名和田 彩, 井上 嘉乃, 上野 匡庸, 有冨 貴史, 中山田 真吾, 田中 良哉
九州リウマチ, Mar. 2019, Reviewed, No invitation

上大静脈症候群を呈した血管型ベーチェット病の1例
上野 匡庸, 中野 和久, 宮川 一平, 中山田 真吾, 岩田 慈, 福與 俊介, 久保 智史, 宮崎 佑介, 河邊 明男, 田中 良哉
九州リウマチ, Sep. 2018, Reviewed, Null
Lead

MPO-ANCA陽性を呈した抗GBM抗体型腎炎の1例
上野 匡庸, 中野 和久, 吉成 紘子, 中山田 真吾, 久保 智史, 宮川 一平, 好川 真以子, 田村 雅仁, 宮本 哲, 齋藤 和義, 田中 良哉
九州リウマチ, Apr. 2018, Reviewed, Null
Lead

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Oct. 2024, Reviewed, No invitation

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo Satoshi, Miyazaki Yusuke, Nishino Takahiro, Fujita Yuya, Kono Michihiro, Kawashima Tsugumi, Ishigaki Kazuyoshi, Kusaka Katsuhide, Tanaka Hiroaki, Ueno Masanobu, Satoh-Kanda Yurie, Inoue Yoshino, Todoroki Yasuyuki, Miyagawa Ippei, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Annals of the rheumatic diseases, Feb. 2025, Reviewed, No invitation

Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase enhancer of zeste homolog 2.
Zhang Mingzeng, Iwata Shigeru, Hajime Maiko, Ohkubo Naoaki, Todoroki Yasuyuki, Miyata Hiroko, Ueno Masanobu, Hao He, Zhang Tong, Fan Jie, Nakayamada Shingo, Yamagata Kaoru, Tanaka Yoshiya
Arthritis & rheumatology (Hoboken, N.J.), Jan. 2020, Reviewed, No invitation

An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis.
Ueno Masanobu, Nakano Kazuhisa, Yoshinari Hiroko, Nakayamada Shingo, Iwata Shigeru, Kubo Satoshi, Miyagawa Ippei, Tanaka Yoshiya
Internal medicine (Tokyo, Japan), Apr. 2019, Reviewed, No invitation
Lead

The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Kawabe Akio, Miyazaki Yusuke, Inoue Yoshino, Ueno Masanobu, Ohkubo Naoaki, Fujita Yuya, Tanaka Yoshiya
International journal of rheumatic diseases, Feb. 2020, Reviewed, No invitation

Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
Miyagawa Ippei, Nakano Kazuhisa, Nakayamada Shingo, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
International journal of rheumatic diseases, Mar. 2019, Reviewed, No invitation

Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth.
Shen Mengyue, Wang Duo, Sennari Yusuke, Zeng Zirui, Baba Ryoko, Morimoto Hiroyuki, Kitamura Noriaki, Nakanishi Tsukasa, Tsukada Junichi, Ueno Masanobu, Todoroki Yasuyuki, Iwata Shigeru, Yonezawa Tomo, Tanaka Yoshiya, Osada Yoshio, Yoshida Yasuhiro
Medical oncology (Northwood, London, England), Jun. 2022, Reviewed, Null

The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis.
Kusaka Katsuhide, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology, Apr. 2025, Reviewed, No invitation

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Nakayama Yoichi, Nagata Wataru, Takeuchi Yoichi, Fukui Sho, Fujita Yuya, Hosokawa Yohei, Ueno Masanobu, Ono Kumiko, Sumitomo Shuji, Tabuchi Yuya, Nakanishi Yuichiro, Saito Shuntaro, Ikeuchi Hiroko, Kawamori Kazutaka, Sofue Hideaki, Doi Goro, Minami Runa, Hirota Tomoya, Minegishi Kaoru, Maeshima Keisuke, Motoyama Ryo, Nakamura Shohei, Suzuki Shotaro, Nishioka Norihiro, Wada Takuma Tsuzuki, Onishi Akira, Nishimura Kenichi, Watanabe Ryu, Yanai Ryo, Kida Takashi, Nishiwaki Hiroki, Yajima Nobuyuki, Kaneko Yuko, Tanaka Eiichi, Kawahito Yutaka, Harigai Masayoshi
Modern rheumatology, Oct. 2024, Reviewed, No invitation

A case of newly onset rheumatoid arthritis successfully treated with methotrexate under the anti-retrovirus therapy against HIV infection.
Ippei Miyagawa,Shingo Nakayamada,Kazuyoshi Saito,Shoichi Shimizu,Kentaro Hanami,Masanobu Ueno,Yoshiya Tanaka
Modern rheumatology case reports, Feb. 2025, Null, Null

A case of Erdheim-Chester disease-a mimicker of IgG4-related disease and large vessel vasculitis.
Miyagawa Ippei, Nakayamada Shingo, Nohara Hirotsugu, Kosaka Shumpei, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology case reports, Dec. 2024, Reviewed, No invitation

An autopsy of a patient with polyarteritis nodosa who developed fatal intestinal perforation accompanied by systemic multiple aneurysms and arterial thrombosis.
Tsugita Nao, Miyagawa Ippei, Ueno Masanobu, Takahashi Miyabi, Kosaka Shumpei, Nakayamada Shingo, Tanaka Yoshiya
Modern rheumatology case reports, Dec. 2024, Reviewed, No invitation

Epstein-Barr virus-encoded RNA-positive lymphocytes in bone marrow and lymph nodes in an autopsy case of TAFRO syndrome.
Tsugita Nao, Miyagawa Ippei, Nakayamada Shingo, Nawata Aya, Kosaka Shumpei, Ueno Masanobu, Tanaka Yoshiya
Modern rheumatology case reports, Jan. 2025, Reviewed, No invitation

Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registry.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Satoh-Kanda Yurie, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
RMD open, Jan. 2025, Reviewed, No invitation

Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus.
Ueno Masanobu, Iwata Shigeru, Yamagata Kaoru, Todoroki Yasuyuki, Sonomoto Koshiro, Nagayasu Atsushi, Miyagawa Ippei, Kubo Satoshi, Miyazaki Yusuke, Miyata Hiroko, Kanda Ryuichiro, Aritomi Takafumi, Nakayamada Shingo, Tanaka Yoshiya
RMD open, Dec. 2024, Reviewed, No invitation
Lead

Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai Hidenori, Miyazaki Yusuke, Nakayamada Shingo, Kubo Satoshi, Hanami Kentaro, Fukuyo Shunsuke, Yamaguchi Ayako, Miyagawa Ippei, Ueno Masanobu, Tanaka Hiroaki, Todoroki Yasuyuki, Ohkubo Naoaki, Funada Masashi, Matsunaga Satsuki, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation

Comparison of anti-IL-6 receptor and JAK inhibitors in patients with rheumatoid arthritis from the real-world practice FIRST study.
Miyazaki Yusuke, Nakayamada Shingo, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Todoroki Yasuyuki, Inoue Yoshino, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Jun. 2024, Reviewed, No invitation

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto Koshiro, Nakayamada Shingo, Fujino Yoshihisa, Miyata Hiroko, Kubo Satoshi, Fujita Yuya, Inoue Yoshino, Matsunaga Satsuki, Iwata Shigeru, Hanami Kentaro, Todoroki Yasuyuki, Yoshinari-Korekoda Hiroko, Kawabe Akio, Yamaguchi Ayako, Ueno Masanobu, Satoh-Kanda Yurie, Kanda Ryuichiro, Funada Masashi, Ohkubo Naoaki, Kusaka Katsuhide, Kosaka Shumpei, Nagayasu Atsushi, Fukuyo Shunsuke, Nawata Masao, Miyazaki Yusuke, Tokunaga Mikiko, Tanaka Kenichi, Okada Yosuke, Tanaka Yoshiya
Rheumatology (Oxford, England), Nov. 2023, Reviewed, No invitation

Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
Miyazaki Yusuke, Funada Masashi, Nakayamada Shingo, Sonomoto Koshiro, Tanaka Hiroaki, Hanami Kentaro, Fukuyo Shunsuke, Kubo Satoshi, Yamaguchi Ayako, Miyagawa Ippei, Todoroki Yasuyuki, Ueno Masanobu, Tanaka Yoshiya
Rheumatology (Oxford, England), Sep. 2024, Reviewed, No invitation

Transition of clinical remission rates with molecular targeted therapies in rheumatoid arthritis in Japan: insights from FIRST registry.
Kubo Satoshi, Miyazaki Yusuke, Tanaka Hiroaki, Fujita Yuya, Sakai Hidenori, Ueno Masanobu, Todoroki Yasuyuki, Satoh-Kanda Yurie, Miyagawa Ippei, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology (Oxford, England), May 2025, Reviewed, No invitation

Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST Registry.
Kanda Ryuichiro, Miyazaki Yusuke, Nakayamada Shingo, Fukuyo Shunsuke, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Satoh-Kanda Yurie, Ohkubo Naoaki, Todoroki Yasuyuki, Tanaka Hiroaki, Ueno Masanobu, Nagayasu Atsushi, Fujita Yuya, Aritomi Takafumi, Kusaka Katsuhide, Sakai Hidenori, Matsunaga Satsuki, Nohara Hirotsugu, Tanaka Yoshiya
Rheumatology and therapy, Mar. 2025, Reviewed, No invitation

Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis.
Nagayasu Atsushi, Miyazaki Yusuke, Sonomoto Koshiro, Kubo Satoshi, Miyagawa Ippei, Yamaguchi Ayako, Tanaka Hiroaki, Todoroki Yasuyuki, Ueno Masanobu, Aritomi Takafumi, Fujita Yuya, Sakai Hidenori, Suzuki Katsunori, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Aug. 2025, Reviewed, No invitation

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo Satoshi, Miyazaki Yusuke, Todoroki Yasuyuki, Nagayasu Atsushi, Kanda Ryuichiro, Aritomi Takafumi, Matsunaga Satsuki, Ueno Masanobu, Miyagawa Ippei, Sonomoto Koshiro, Hanami Kentaro, Nakayamada Shingo, Tanaka Yoshiya
Rheumatology and therapy, Oct. 2023, Reviewed, No invitation